The impact of wounds on the progression and treatment of cancer is highlighted in this review. The goal of this review is to look into the process of wound healing and how it relates to cancer evolution and treatment. Proliferation and terminal differentiation (TD) of progenitor stem cells (PSCs), the progenitors of cancer stem cells, are required for wound healing (CSCs). It is not difficult to heal a wound. If the chemo-surveillance system is working properly, such as in healthy people who can keep a constant level of wound healing metabolites acting as differentiation inducers (DIs) and differentiation helper inducers (DHIs). Wounds are always properly healed without any effort on the part of the patient; all that is required is for the patient to relax and allow nature to cure the wound. Sutures and antibiotics are used as a last resort to speed up the healing process or avoid infection. The functionality of chemo-surveillance is momentarily harmed by an acute wound, which heals fast and returns to normal. Chronic wounds, such as persistent viral illnesses or long-term exposure to toxic substances, especially carcinogens, have a negative impact on chemo-surveillance functionality. Wound healing is hampered by the generation of inflammatory cytokines, which promote increased urine excretion of wound repair metabolites. It is relatively easy for PSCs to transition into CSCs if there aren't enough wound healing metabolites to stop PCSs from proliferating. To complete the change, all it takes is a single hit to silence the TET-1 enzyme, which is well within the reach of PSCs with abnormally active methylation enzymes (MEs). The activation of oncogenes or the silencing of oncogenes in CSCs can then lead to the development of faster growing cancer cells (AML). MDS and AML aren't the only ones who get cancer because their wounds don't heal properly. It's a rather typical occurrence. The war on cancer can be easily won if the combat is performed in accordance with nature's path for healing the wound, similar to the success of wound healing in healthy people without exerting any effort. As a result, using DIs and DHIs to restore chemo-surveillance functionality and anti-cachexia compounds like phenylacetylglutamine to prevent the loss of wound healing metabolites is the greatest way to win the war on cancer. The proliferation of cells with aberrant MEs, such as CSCs, PSCs, and all cancer cells, will thereafter be stopped by nature. Destruction as a method of killing cancer cells is clearly counterproductive. It causes more damage to the chemo-surveillance system's ability to inhibit the proliferation of cells with aberrant MEs. The failure of the destruction strategy to eliminate CSCs is a deciding factor in denying the destruction approach's ability to win the cancer fight.
Author(S) Details
Ming C. Liau
CDA Therapeutics, Inc, 3308 Sky Run Court, Missouri City, TX 77459, USA.
Linda Liau Baker
CDA Therapeutics, Inc, 3308 Sky Run Court, Missouri City, TX 77459, USA.
View Book:- https://stm.bookpi.org/RDMMR-V8/article/view/4573
No comments:
Post a Comment